Login
| TI Ref No : | 527904902 |
|---|---|
| Description : | A Laronidase (genetical Recombination) (2.9mg 5ml×1vial/case) 2,025 Cases,b Ravulizumab (genetical Recombination) (300mg 3ml×1vial/case) 242 Cases,c Ravulizumab (genetical Recombination) (1100mg 11ml×1vial/case) 68 Cases,d Inebilizumab (ge... |
| Date : | 2026-01-23 |
| Deadline : | 2026-03-17 |
| Document Type : | Tenders |
